The 'antigen problem', i.e. the disconnect between the broad spectrum of therapeutic modes enabled by the range of viral and synthetic nanoparticles for which workable receptor-targeting architectures exist and the relative dearth of addressable target receptors on most tumors, is a long-standing challenge in targeted tumor nanotherapy. Here we provide in vitro-proof-of-principle for NanoPro, a…
Two-time Olympic gold medalist snowboarder Chloe Kim discusses how her recent diagnosis with attention-deficit hyperactivity disorder took a while and her ADHD treatment
Medical experts have advised women to prioritise their health and well-being by paying attention to their bodies and adopting healthy lifestyles to reduce Read More…
